Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04411914 · ClinicalTrials.gov registry record · Phase 1
Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid
A Phase 1 study, sponsored by Temple University.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT04411914 is a Phase 1 study that has completed, run by Temple University. The registered enrollment target is 13 participants.
The verdict
NCT04411914, a Phase 1 study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
A dose-escalation study to determine the optimum dose of Clavulanic Acid (CLAV) for effects on craving and efficacy.
Interventions
- OTHER Placebo
- DRUG Clavulanic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04411914
The ClinicalTrials.gov registry entry for NCT04411914 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04411914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04411914 about?
NCT04411914 is a clinical study titled "Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid". A dose-escalation study to determine the optimum dose of Clavulanic Acid (CLAV) for effects on craving and efficacy.
What is the current status of trial NCT04411914?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2020-09-01. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04411914?
The interventions under investigation include: Placebo (OTHER), Clavulanic Acid (DRUG).
Who is sponsoring clinical trial NCT04411914?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.